AU2003276221A1 - Diagnostics and therapeutics for diseases associated with endothelial differentiation, sphingolipid g-protein-coupled receptor 4 (edg4) - Google Patents
Diagnostics and therapeutics for diseases associated with endothelial differentiation, sphingolipid g-protein-coupled receptor 4 (edg4)Info
- Publication number
- AU2003276221A1 AU2003276221A1 AU2003276221A AU2003276221A AU2003276221A1 AU 2003276221 A1 AU2003276221 A1 AU 2003276221A1 AU 2003276221 A AU2003276221 A AU 2003276221A AU 2003276221 A AU2003276221 A AU 2003276221A AU 2003276221 A1 AU2003276221 A1 AU 2003276221A1
- Authority
- AU
- Australia
- Prior art keywords
- edg4
- sphingolipid
- therapeutics
- diagnostics
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 101710198859 G-protein coupled receptor 4 Proteins 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000009762 endothelial cell differentiation Effects 0.000 title 1
- 102000044101 human GPR4 Human genes 0.000 title 1
- 150000003408 sphingolipids Chemical class 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02025099 | 2002-11-13 | ||
| EP02025099.9 | 2002-11-13 | ||
| PCT/EP2003/012126 WO2004044588A1 (en) | 2002-11-13 | 2003-10-31 | Diagnostics and therapeutics for diseases associated with endothelial differentiation, sphingolipid g-protein-coupled receptor 4 (edg4) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003276221A1 true AU2003276221A1 (en) | 2004-06-03 |
Family
ID=32309328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003276221A Abandoned AU2003276221A1 (en) | 2002-11-13 | 2003-10-31 | Diagnostics and therapeutics for diseases associated with endothelial differentiation, sphingolipid g-protein-coupled receptor 4 (edg4) |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1597581A1 (en) |
| AU (1) | AU2003276221A1 (en) |
| WO (1) | WO2004044588A1 (en) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037146A (en) * | 1997-01-28 | 2000-03-14 | Smithkline Beecham Corporation | CDNA clone HE8CH90 that encodes a novel 7-transmembrane receptor |
| US6020158A (en) * | 1997-05-22 | 2000-02-01 | Allelix Biopharmaceuticals, Inc. | Isolated polynucleotide for novel G-protein coupled receptor |
| JP2002500041A (en) * | 1997-12-30 | 2002-01-08 | エヌピーエス アレリックス コーポレーション | Identification of lysolipid receptor involved in inflammatory response |
| US6812335B1 (en) * | 1999-03-23 | 2004-11-02 | The Regents Of The University Of California | Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same |
| WO2001071022A2 (en) * | 2000-03-17 | 2001-09-27 | The University Of Tennessee Research Corporation | Lpa receptor agonists and antagonists and methods of use |
| EP1361872A4 (en) * | 2000-10-03 | 2004-05-19 | Univ Virginia | NEW LYSOPHOSPHIC ACID RECEPTOR AGONISTS AND ANTAGONISTS |
-
2003
- 2003-10-31 AU AU2003276221A patent/AU2003276221A1/en not_active Abandoned
- 2003-10-31 WO PCT/EP2003/012126 patent/WO2004044588A1/en not_active Application Discontinuation
- 2003-10-31 EP EP03810958A patent/EP1597581A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1597581A1 (en) | 2005-11-23 |
| WO2004044588A1 (en) | 2004-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002360818A1 (en) | 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor | |
| AU2002364035A1 (en) | 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor | |
| AU2003242046A1 (en) | Sustained-release composition, process for producing the same and preparation thereof | |
| AU2003286055A1 (en) | Self adjusting, high strength, screw system | |
| AU2003244637A1 (en) | Diagnostics and therapeutics for diseases associated with homo sapiens putative neurotransmitter receptor (pnr) | |
| AU2002218919A1 (en) | Compositions and methods for regulating receptor clustering | |
| AU2002305308A1 (en) | Hydrophilic finish for fibrous substrates | |
| AU2002363338A1 (en) | Diagnostics and therapeutics for ocular abnormalities | |
| AU2003276221A1 (en) | Diagnostics and therapeutics for diseases associated with endothelial differentiation, sphingolipid g-protein-coupled receptor 4 (edg4) | |
| AU2003278165A1 (en) | Diagnostics and therapeutics for diseases associated with human endothelial differentiation, lysophosphatidic acid g-protein-coupled receptor 2 (edg2) | |
| AU2003301991A1 (en) | Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 5 (edg5) | |
| AU2003287976A1 (en) | Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 3 (edg3) | |
| AU2003273994A1 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) | |
| AU2003229767A1 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9) | |
| AU2003210256A1 (en) | Diagnostics and therapeutics for diseases associated with endothelial differentiation lysophosphatic acid g-protein-coupled receptor 7 (edg7) | |
| AU2003240720A1 (en) | Diagnostics and therapeutics for diseases associated with somatostatin receptor 5 (sstr5) | |
| AU2003205627A1 (en) | Diagnostics and therapeutics for diseases associated with gpr72 | |
| AU2003229753A1 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8) | |
| AU2003216866A1 (en) | Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) | |
| AU2003229736A1 (en) | Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1) | |
| AU2003212356A1 (en) | Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 8 (gpr8) | |
| AU2003227065A1 (en) | Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 63 (gpr63) | |
| AU2003250221A1 (en) | Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 6(cxcr6) | |
| AU2003298111A1 (en) | Diagnostics and therapeutics for diseases associated with bile acid g-protein-coupled receptor 37 (bg37) | |
| AU2003227064A1 (en) | Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |